Biomarkers for the Detection of Renal Fibrosis and Prediction of Renal Outcomes: a Systematic Review

Overview

Journal BMC Nephrol

Publisher Biomed Central

Specialty Nephrology

Date 2017 Feb 22

PMID 28219345

Citations 60

Authors

Sherry G Mansour

Jeremy Puthumana

Steven G Coca

Mark Gentry

Chirag R Parikh

Affiliations

Soon will be listed here.

Abstract

Background: Fibrosis is the unifying pathway leading to chronic kidney disease. Identifying biomarkers of fibrosis may help predict disease progression.

Methods: We performed a systematic review to evaluate the reliability of blood and urine biomarkers in identifying fibrosis on biopsy as well as predicting renal outcomes. Using MEDLINE and EMBASE, a two-stage search strategy was implemented. Stage I identified a library of biomarkers correlating with fibrosis on biopsy. Stage II evaluated the association between biomarkers identified in stage I, and renal outcomes. Only biomarkers with moderate positive correlation with fibrosis (r > 0.40) or acceptable area under the curve (AUC >0.65) advanced to stage II.

Results: Stage I identified 17 studies and 14 biomarkers. Five biomarkers met criteria to advance to stage II, but only three were independently associated with renal outcomes. Transforming growth factor β (TGF-β) correlated with fibrosis (r = 0.60), and was associated with 1.7-3.9 times the risk of worsening renal function in 426 patients. Monocyte chemoattractant protein-1 (MCP-1) diagnosed fibrosis with AUC of 0.66 and was associated with 2.3-11.0 times the risk of worsening renal function in 596 patients. Matrix metalloproteinase-2 (MMP-2) correlated with fibrosis (r = 0.41), and was associated with 2.5 times the risk of worsening renal function.

Conclusions: Given the heterogeneity of the data due to diverse patient populations along with differing renal outcomes, a meta-analysis could not be conducted. Nonetheless we can conclude from the published data that TGF-β, MCP-1 and MMP-2 may identify patients at risk for renal fibrosis and hence worse renal outcomes.

Citing Articles

Mechanisms underlying the involvement of peritoneal macrophages in the pathogenesis and novel therapeutic strategies for dialysis-induced peritoneal fibrosis.

Wang Y, Zhang Y, Ma M, Zhuang X, Lu Y, Miao L Front Immunol. 2025; 15:1507265.

PMID: 39749340 PMC: 11693514. DOI: 10.3389/fimmu.2024.1507265.

Menaquinone-7 and its therapeutic potential in type 2 diabetes mellitus based on a Zucker diabetic fatty rat model.

Mrosewski I, Mantel V, Urbank M, Schulze-Tanzil G, Werner C, Gogele C Heliyon. 2024; 10(23):e40826.

PMID: 39719993 PMC: 11666950. DOI: 10.1016/j.heliyon.2024.e40826.

Ultrasonic renal length as an indicator of renal fibrosis severity in non-diabetic patients with chronic kidney disease.

Chen Z, Jiang J, Gunda S, Han X, Wu C, Ying M Clin Exp Nephrol. 2024; .

PMID: 39560816 DOI: 10.1007/s10157-024-02598-0.

Towards clinical translation of urinary vitronectin for non-invasive detection and monitoring of renal fibrosis in kidney transplant patients.

Clos-Sansalvador M, Taco O, Rodriguez-Martinez P, Garcia S, Font-Moron M, Bover J J Transl Med. 2024; 22(1):1030.

PMID: 39548536 PMC: 11566717. DOI: 10.1186/s12967-024-05777-5.

Transition from acute kidney injury to chronic kidney disease in a long-term murine model of Shiga toxin-induced hemolytic-uremic syndrome.

Wegener J, Dennhardt S, Loeffler I, Coldewey S Front Immunol. 2024; 15:1469353.

PMID: 39450175 PMC: 11499141. DOI: 10.3389/fimmu.2024.1469353.

References

Shi Y, Su T, Qu L, Wang C, Li X, Yang L . Evaluation of urinary biomarkers for the prognosis of drug-associated chronic tubulointerstitial nephritis. Am J Med Sci. 2012; 346(4):283-8. DOI: 10.1097/MAJ.0b013e318271f910. View

Pepe M, Etzioni R, Feng Z, Potter J, Thompson M, Thornquist M . Phases of biomarker development for early detection of cancer. J Natl Cancer Inst. 2001; 93(14):1054-61. DOI: 10.1093/jnci/93.14.1054. View

Bossuyt P, Reitsma J, Bruns D, Gatsonis C, Glasziou P, Irwig L . The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med. 2003; 138(1):W1-12. DOI: 10.7326/0003-4819-138-1-200301070-00012-w1. View

Kahu J, Kyllonen L, Raisanen-Sokolowski A, Salmela K . Donor risk score and baseline biopsy CADI value predict kidney graft outcome. Clin Transplant. 2011; 25(3):E276-83. DOI: 10.1111/j.1399-0012.2011.01401.x. View

Du X, Shimizu A, Masuda Y, Kuwahara N, Arai T, Kataoka M . Involvement of matrix metalloproteinase-2 in the development of renal interstitial fibrosis in mouse obstructive nephropathy. Lab Invest. 2012; 92(8):1149-60. DOI: 10.1038/labinvest.2012.68. View

Nadkarni G, Rao V, Ismail-Beigi F, Fonseca V, Shah S, Simonson M . Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial. Clin J Am Soc Nephrol. 2016; 11(8):1343-1352. PMC: 4974890. DOI: 10.2215/CJN.12051115. View

Wong M, Perkovic V, Woodward M, Chalmers J, Li Q, Hillis G . Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus. Kidney Int. 2012; 83(2):278-84. DOI: 10.1038/ki.2012.383. View

Chen X, Zhu W, Al-Hayek S, Yan X, Jiang C, Zheng X . Urinary TGF-1 has a supplementary value in predicting renal function recovery post unilateral ureteral obstruction. Int Urol Nephrol. 2014; 47(1):33-7. DOI: 10.1007/s11255-014-0846-3. View

Koesters R, Kaissling B, Lehir M, Picard N, Theilig F, Gebhardt R . Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol. 2010; 177(2):632-43. PMC: 2913362. DOI: 10.2353/ajpath.2010.091012. View

10.

Kitagawa K, Wada T, Furuichi K, Hashimoto H, Ishiwata Y, Asano M . Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol. 2004; 165(1):237-46. PMC: 1618531. DOI: 10.1016/S0002-9440(10)63292-0. View

11.

Ghoul B, Squalli T, Servais A, Elie C, Meas-Yedid V, Trivint C . Urinary procollagen III aminoterminal propeptide (PIIINP): a fibrotest for the nephrologist. Clin J Am Soc Nephrol. 2010; 5(2):205-10. PMC: 2827599. DOI: 10.2215/CJN.06610909. View

12.

Verhave J, Bouchard J, Goupil R, Pichette V, Brachemi S, Madore F . Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: a prospective study. Diabetes Res Clin Pract. 2013; 101(3):333-40. DOI: 10.1016/j.diabres.2013.07.006. View

13.

Lu X, Li M, Zhou L, Jiang H, Wang H, Chen J . Urinary serum- and glucocorticoid-inducible kinase SGK1 reflects renal injury in patients with immunoglobulin A nephropathy. Nephrology (Carlton). 2014; 19(6):307-17. DOI: 10.1111/nep.12225. View

14.

Bhangoo R, Hall I, Reese P, Parikh C . Deceased-donor kidney perfusate and urine biomarkers for kidney allograft outcomes: a systematic review. Nephrol Dial Transplant. 2012; 27(8):3305-14. PMC: 3716303. DOI: 10.1093/ndt/gfr806. View

15.

Parikh C, Thiessen-Philbrook H, Garg A, Kadiyala D, Shlipak M, Koyner J . Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. Clin J Am Soc Nephrol. 2013; 8(7):1079-88. PMC: 3700701. DOI: 10.2215/CJN.10971012. View

16.

Lee H, Lee M, Lee S, Lee S, Lee E, Lee E . Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system. Nephrol Dial Transplant. 2004; 20(2):342-8. DOI: 10.1093/ndt/gfh633. View

17.

Sanders J, Huitema M, Hanemaaijer R, Goor H, Kallenberg C, Stegeman C . Urinary matrix metalloproteinases reflect renal damage in anti-neutrophil cytoplasm autoantibody-associated vasculitis. Am J Physiol Renal Physiol. 2007; 293(6):F1927-34. DOI: 10.1152/ajprenal.00310.2007. View

18.

Zhu L, Shi S, Liu L, Lv J, Zhang H . Increased plasma sVCAM-1 is associated with severity in IgA nephropathy. BMC Nephrol. 2013; 14:21. PMC: 3557193. DOI: 10.1186/1471-2369-14-21. View

19.

Zhang X, Nagaraja H, Nadasdy T, Song H, McKinley A, Prosek J . A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies. Kidney Int. 2011; 81(4):401-6. PMC: 3640330. DOI: 10.1038/ki.2011.354. View

20.

Cattran D, Coppo R, Cook H, Feehally J, Roberts I, Troyanov S . The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009; 76(5):534-45. DOI: 10.1038/ki.2009.243. View